Jyh-Haur Chern Selected Research

N- (3- methyl- 5- isothiazolyl)- 2- 1- ((3- methyl- 5- isoxazolyl)methyl)- 1H- 3- indolyl- 2- oxoacetamide

1/2011

BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jyh-Haur Chern Research Topics

Disease

3	Virus Diseases (Viral Diseases) 12/2020 - 07/2009
2	Infections 04/2019 - 04/2002
2	Neoplasms (Cancer) 04/2011 - 01/2011
2	Rhabdomyosarcoma 10/2004 - 05/2004
1	Hepatitis C 01/2018
1	Lung Neoplasms (Lung Cancer) 04/2011
1	Leukemia 01/2011
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2011
1	Atherosclerosis 10/2008
1	Inflammation (Inflammations) 10/2008

Drug/Important Bio-Agent (IBA)

2	Antiviral Agents (Antivirals)IBA 01/2018 - 04/2002
1	P-selectin ligand proteinIBA 12/2020
1	Scavenger Receptors (Scavenger Receptor)IBA 12/2020
1	Heparitin Sulfate (Heparan Sulfate)IBA 12/2020
1	Capsid Proteins (Capsid Protein)IBA 01/2016
1	dicyandiamido (cyanoguanidine)IBA 04/2011
1	PyrimidinonesIBA 04/2011
1	Colchicine FDA LinkGeneric 01/2011
1	N- (3- methyl- 5- isothiazolyl)- 2- 1- ((3- methyl- 5- isoxazolyl)methyl)- 1H- 3- indolyl- 2- oxoacetamideIBA 01/2011
1	Cisplatin (Platino)FDA LinkGeneric 01/2011
1	Viral RNAIBA 07/2009
1	Ether (Diethyl Ether)IBA 10/2004
1	OximesIBA 10/2004
1	PyrimidinesIBA 05/2004
1	ThiophenesIBA 05/2004

Therapy/Procedure

2	Therapeutics 04/2011 - 10/2008
1	Oral Administration 04/2019